D000925Chemicals & DrugsD27.505.954.502.1193657840.641324AnticoagulantsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPulmonary MedicineMD AndersonTHEIN HLAINGOOTHEIN HLAING OO9678OO, THEIN HLAINGProfessor74Professor10Assistant ProfessorCHSA Pedi-Hospital MedicineDepartment of Emergency MedicineEmergency Medicinetrue1ProfessorProfessortrue1ProfessorProfessor4.612810.00369372365research area of0.9473510.0191429616subject area forDepartment of MedicineDepartment of PediatricsMedicine-Hematology & OncologyMedicine-NephrologyBaylor College of MedicineWILLIAMPEACOCKWILLIAM PEACOCK0.000000000000000.000000000000004378PEACOCK, WILLIAMProfessorBRADYMOFFETTBRADY MOFFETT0.000000000000000.000000000000004738MOFFETT, BRADYAssistant Professortrue1Assistant ProfessorAssistant ProfessorANGLIANG LI15508LI, ANGAssistant Professor35776377Mohan A, Majd Z, Trinh T, Paranjpe R, Abughosh SMInternational journal of clinical pharmacyGroup based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study. Int J Clin Pharm. 2022 Aug; 44(4):966-974.Int J Clin Pharm2022-07-01T00:00:002022Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.35909257Mitchell LG, R?shammar D, Huang F, Albisetti M, Brand?o LR, Bomgaars L, Chalmers E, Halton J, Luciani M, Joseph D, Tartakovsky I, Gropper S, Brueckmann MThrombosis and haemostasisAnticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials. Thromb Haemost. 2022 Sep; 122(9):1573-1583.Thromb Haemost2022-07-31T00:00:002022Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials.36054446Dinunno CV, Lopez CN, Succar L, Nguyen DT, Graviss EA, Salazar E, Donahue KRPharmacotherapyDirect oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations. Pharmacotherapy. 2022 10; 42(10):768-779.Pharmacotherapy2022-09-12T00:00:002022Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations.37093601Cannon CP, Kim JM, Lee JJ, Sutherland J, Bachireddy R, Valentine CM, Hearne S, Trebnick A, Jaffer S, Datta S, Semmel E, Thorpe F, Doros G, Cavender MA, Reynolds MR, Benchmarking an Oral Anticoagulant Treatment Rate in Patients with Nonvalvular Atrial Fibrillation (JAMA network openPatients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant. JAMA Netw Open. 2023 04 03; 6(4):e239638.JAMA Netw Open2023-04-03T00:00:002023Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant.37317991Roccograndi LM, Lovell AR, Ferrajoli A, Thompson PA, Burger JA, Wierda WG, Jain N, Rausch CRLeukemia & lymphomaIncidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation. Leuk Lymphoma. 2023 09; 64(9):1554-1561.Leuk Lymphoma2023-06-15T00:00:002023Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessorWOLFGANGWINKELMAYERWOLFGANG WINKELMAYER7258WINKELMAYER, WOLFGANGProfessor